{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:29:23Z","timestamp":1791379763956,"version":"4.3.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["Grant no. 2020R1A6A1A03044512"],"award-info":[{"award-number":["Grant no. 2020R1A6A1A03044512"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute of Planning and Evaluation for Technology in Food and Agriculture","award":["Grant no. 321026-05"],"award-info":[{"award-number":["Grant no. 321026-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11030-024-10825-9","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:01:52Z","timestamp":1718967712000},"page":"4425-4439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biocomputational screening of natural compounds targeting 15-hydroxyprostaglandin dehydrogenase to improve skeletal muscle during aging"],"prefix":"10.1007","volume":"28","author":[{"given":"Syed Sayeed","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"10825_CR1","doi-asserted-by":"publisher","unstructured":"Lee EJ, Shaikh S, Baig MH, Park SY, Lim JH, Ahmad SS, Ali S, Ahmad K, Choi I (2022) MIF1 and MIF2 myostatin peptide inhibitors as potent muscle Mass regulators. Int J Mol Sci 23(8). https:\/\/doi.org\/10.3390\/ijms23084222","DOI":"10.3390\/ijms23084222"},{"key":"10825_CR2","doi-asserted-by":"publisher","unstructured":"Ahmad K, Lee EJ, Moon JS, Park SY, Choi I (2018) Multifaceted interweaving between extracellular matrix, insulin resistance, and skeletal muscle. Cells 7(10). https:\/\/doi.org\/10.3390\/cells7100148","DOI":"10.3390\/cells7100148"},{"key":"10825_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fphar.2020.00142","volume":"11","author":"K Ahmad","year":"2020","unstructured":"Ahmad K, Shaikh S, Ahmad SS, Lee EJ, Choi I (2020) Cross-talk between Extracellular Matrix and skeletal muscle: implications for myopathies. Front Pharmacol 11:142. https:\/\/doi.org\/10.3389\/fphar.2020.00142","journal-title":"Front Pharmacol"},{"issue":"8","key":"10825_CR4","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1096\/fj.201500133R","volume":"30","author":"EJ Lee","year":"2016","unstructured":"Lee EJ, Jan AT, Baig MH, Ashraf JM, Nahm SS, Kim YW, Park SY, Choi I (2016) Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program. FASEB J 30(8):2708\u20132719. https:\/\/doi.org\/10.1096\/fj.201500133R","journal-title":"FASEB J"},{"issue":"12","key":"10825_CR5","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1242\/dev.151035","volume":"144","author":"J Chal","year":"2017","unstructured":"Chal J, Pourquie O (2017) Making muscle: skeletal myogenesis in vivo and in vitro. Development 144(12):2104\u20132122. https:\/\/doi.org\/10.1242\/dev.151035","journal-title":"Development"},{"issue":"3","key":"10825_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-021-00421-2","volume":"23","author":"P Sousa-Victor","year":"2022","unstructured":"Sousa-Victor P, Garcia-Prat L, Munoz-Canoves P (2022) Control of satellite cell function in muscle regeneration and its disruption in ageing. Nat Rev Mol Cell Biol 23(3):204\u2013226. https:\/\/doi.org\/10.1038\/s41580-021-00421-2","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10825_CR7","doi-asserted-by":"publisher","unstructured":"Ahmad SS, Ahmad K, Lee EJ, Lee YH, Choi I (2020) Implications of insulin-like Growth Factor-1 in skeletal muscle and various diseases. Cells 9(8). https:\/\/doi.org\/10.3390\/cells9081773","DOI":"10.3390\/cells9081773"},{"issue":"17","key":"10825_CR8","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.7150\/thno.45434","volume":"10","author":"X Cao","year":"2020","unstructured":"Cao X, Duan L, Hou H, Liu Y, Chen S, Zhang S, Liu Y, Wang C, Qi X, Liu N, Han Z, Zhang D, Han ZC, Guo Z, Zhao Q, Li Z (2020) IGF-1\u00a0C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE(2)-mediated M2 macrophage polarization. Theranostics 10(17):7697\u20137709. https:\/\/doi.org\/10.7150\/thno.45434","journal-title":"Theranostics"},{"issue":"19","key":"10825_CR9","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.7150\/thno.27385","volume":"8","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Zhang X, Zhu D, Qi X, Cao X, Fang Y, Che Y, Han ZC, He ZX, Han Z, Li Z (2018) Prostaglandin E(2) hydrogel improves cutaneous wound healing via M2 macrophages polarization. Theranostics 8(19):5348\u20135361. https:\/\/doi.org\/10.7150\/thno.27385","journal-title":"Theranostics"},{"key":"10825_CR10","doi-asserted-by":"publisher","unstructured":"Palla AR, Ravichandran M, Wang YX, Alexandrova L, Yang AV, Kraft P, Holbrook CA, Schurch CM, Ho ATV, Blau HM (2021) Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science 371(6528). https:\/\/doi.org\/10.1126\/science.abc8059","DOI":"10.1126\/science.abc8059"},{"issue":"26","key":"10825_CR11","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1073\/pnas.1705420114","volume":"114","author":"ATV Ho","year":"2017","unstructured":"Ho ATV, Palla AR, Blake MR, Yucel ND, Wang YX, Magnusson KEG, Holbrook CA, Kraft PE, Delp SL, Blau HM (2017) Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc Natl Acad Sci U S A 114(26):6675\u20136684. https:\/\/doi.org\/10.1073\/pnas.1705420114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10825_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/onc.2013.69","volume":"33","author":"D Lu","year":"2014","unstructured":"Lu D, Han C, Wu T (2014) 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2\/PPARgamma-mediated activation of p21WAF1\/Cip1. Oncogene 33(9):1101\u20131112. https:\/\/doi.org\/10.1038\/onc.2013.69","journal-title":"Oncogene"},{"key":"10825_CR13","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.phrs.2021.105807","volume":"172","author":"L Yin","year":"2021","unstructured":"Yin L, Li N, Jia W, Wang N, Liang M, Yang X, Du G (2021) Skeletal muscle atrophy: from mechanisms to treatments. Pharmacol Res 172:105807. https:\/\/doi.org\/10.1016\/j.phrs.2021.105807","journal-title":"Pharmacol Res"},{"key":"10825_CR14","doi-asserted-by":"publisher","unstructured":"Ahmad SS, Ahmad K, Shaikh S, You HJ, Lee EY, Ali S, Lee EJ, Choi I (2022) Molecular mechanisms and Current Treatment options for Cancer Cachexia. Cancers (Basel) 14(9). https:\/\/doi.org\/10.3390\/cancers14092107","DOI":"10.3390\/cancers14092107"},{"issue":"9","key":"10825_CR15","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1021\/acs.jmedchem.7b00271","volume":"60","author":"MI Antczak","year":"2017","unstructured":"Antczak MI, Zhang Y, Wang C, Doran J, Naidoo J, Voruganti S, Williams NS, Markowitz SD, Ready JM (2017) Inhibitors of 15-Prostaglandin dehydrogenase to potentiate tissue repair. J Med Chem 60(9):3979\u20134001. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00271","journal-title":"J Med Chem"},{"key":"10825_CR16","doi-asserted-by":"publisher","unstructured":"Mallipeddi PL, Zhang Y, Li H, Markowitz SD, Posner B (2021) Structural insights into Novel 15-Prostaglandin dehydrogenase inhibitors. Molecules 26(19). https:\/\/doi.org\/10.3390\/molecules26195903","DOI":"10.3390\/molecules26195903"},{"issue":"1","key":"10825_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jaci.2015.06.030","volume":"137","author":"V Kondeti","year":"2016","unstructured":"Kondeti V, Al-Azzam N, Duah E, Thodeti CK, Boyce JA, Paruchuri S (2016) Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3. J Allergy Clin Immunol 137(1):289\u2013298. https:\/\/doi.org\/10.1016\/j.jaci.2015.06.030","journal-title":"J Allergy Clin Immunol"},{"issue":"20","key":"10825_CR18","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/01.CIR.0000128046.54681.97","volume":"109","author":"CY Xiao","year":"2004","unstructured":"Xiao CY, Yuhki K, Hara A, Fujino T, Kuriyama S, Yamada T, Takayama K, Takahata O, Karibe H, Taniguchi T, Narumiya S, Ushikubi F (2004) Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation 109(20):2462\u20132468. https:\/\/doi.org\/10.1161\/01.CIR.0000128046.54681.97","journal-title":"Circulation"},{"issue":"5","key":"10825_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1152\/japplphysiol.00396.2015","volume":"120","author":"SZ Liu","year":"2016","unstructured":"Liu SZ, Jemiolo B, Lavin KM, Lester BE, Trappe SW, Trappe TA (2016) Prostaglandin E2\/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age. J Appl Physiol (1985) 120(5):546\u2013551. https:\/\/doi.org\/10.1152\/japplphysiol.00396.2015","journal-title":"J Appl Physiol (1985)"},{"key":"10825_CR20","doi-asserted-by":"publisher","unstructured":"Markworth JF, Cameron-Smith D (2011) Prostaglandin F2&alpha; stimulates PI3K\/ERK\/mTOR signaling and skeletal myotube hypertrophy. Am J Physiol Cell Physiol 300 (3):C671-682. https:\/\/doi.org\/10.1152\/ajpcell.00549.2009","DOI":"10.1152\/ajpcell.00549.2009"},{"issue":"5","key":"10825_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1381612822666151125000550","volume":"22","author":"MH Baig","year":"2016","unstructured":"Baig MH, Ahmad K, Roy S, Ashraf JM, Adil M, Siddiqui MH, Khan S, Kamal MA, Provaznik I, Choi I (2016) Computer aided Drug Design: Success and limitations. Curr Pharm Des 22(5):572\u2013581. https:\/\/doi.org\/10.2174\/1381612822666151125000550","journal-title":"Curr Pharm Des"},{"issue":"18","key":"10825_CR22","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.2174\/1389557521666210405162006","volume":"21","author":"A Muzammil","year":"2021","unstructured":"Muzammil A, Waqas M, Umar A, Sufyan M, Rehman A, Haider A, Akram H, Khan SAF, Afzal M, Wajid M, Tahir RA, Sehgal SA (2021) Anti-aging natural compounds and their role in the regulation of metabolic pathways leading to longevity. Mini Rev Med Chem 21(18):2630\u20132656. https:\/\/doi.org\/10.2174\/1389557521666210405162006","journal-title":"Mini Rev Med Chem"},{"key":"10825_CR23","doi-asserted-by":"publisher","unstructured":"Akter R, Afrose A, Rahman MR, Chowdhury R, Nirzhor SSR, Khan RI, Kabir MT (2021) A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer\u2019s Disease, Aging, Cancer, Inflammation, and Diabetes. Int J Mol Sci 22(8). https:\/\/doi.org\/10.3390\/ijms22084180","DOI":"10.3390\/ijms22084180"},{"issue":"W1","key":"10825_CR24","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian W, Chen C, Lei X, Zhao J, Liang J (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46(W1):W363\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gky473","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10825_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3324\/haematol.2017.178376","volume":"103","author":"A Desai","year":"2018","unstructured":"Desai A, Zhang Y, Park Y, Dawson DM, Larusch GA, Kasturi L, Wald D, Ready JM, Gerson SL, Markowitz SD (2018) A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 103(6):1054\u20131064. https:\/\/doi.org\/10.3324\/haematol.2017.178376","journal-title":"Haematologica"},{"key":"10825_CR26","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"issue":"9","key":"10825_CR27","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires DE, Blundell TL, Ascher DB (2015) pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity properties using graph-based signatures. J Med Chem 58(9):4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"issue":"4","key":"10825_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"},{"issue":"1","key":"10825_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1(1):55\u201368. https:\/\/doi.org\/10.1021\/cc9800071","journal-title":"J Comb Chem"},{"issue":"12","key":"10825_CR30","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45(12):2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"issue":"21","key":"10825_CR31","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM Jr., Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43(21):3867\u20133877. https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"issue":"3","key":"10825_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/med.10041","volume":"23","author":"I Muegge","year":"2003","unstructured":"Muegge I (2003) Selection criteria for drug-like compounds. Med Res Rev 23(3):302\u2013321. https:\/\/doi.org\/10.1002\/med.10041","journal-title":"Med Res Rev"},{"issue":"11","key":"10825_CR33","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2013Ligand Discovery for everyone. J Chem Inf Model 55(11):2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"key":"10825_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19","journal-title":"Methods Mol Biol"},{"key":"10825_CR35","unstructured":"ElTijani A, Alsafi M, Ahmed A (2019) EasyDockVina: graphical interface for Ligand Optimization and high Throughput virtual screening with Vina. Zenodo"},{"issue":"16","key":"10825_CR36","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"16","key":"10825_CR37","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"issue":"4","key":"10825_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.carres.2008.12.025","volume":"344","author":"L Pol-Fachin","year":"2009","unstructured":"Pol-Fachin L, Fernandes CL, Verli H (2009) GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations. Carbohydr Res 344(4):491\u2013500. https:\/\/doi.org\/10.1016\/j.carres.2008.12.025","journal-title":"Carbohydr Res"},{"issue":"Pt 8","key":"10825_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf AW, van Aalten DM (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60(Pt 8):1355\u20131363. https:\/\/doi.org\/10.1107\/S0907444904011679","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"12","key":"10825_CR40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJ, Fraaije JG (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18(12):1463\u20131472","journal-title":"J Comput Chem"},{"issue":"12","key":"10825_CR41","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/nrd4128","volume":"12","author":"JG Cumming","year":"2013","unstructured":"Cumming JG, Davis AM, Muresan S, Haeberlein M, Chen H (2013) Chemical predictive modelling to improve compound quality. Nat Rev Drug Discov 12(12):948\u2013962. https:\/\/doi.org\/10.1038\/nrd4128","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10825_CR42","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H van de Waterbeemd","year":"2003","unstructured":"van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2(3):192\u2013204. https:\/\/doi.org\/10.1038\/nrd1032","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10825_CR43","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41467-023-36463-7","volume":"14","author":"W Huang","year":"2023","unstructured":"Huang W, Li H, Kiselar J, Fink SP, Regmi S, Day A, Yuan Y, Chance M, Ready JM, Markowitz SD, Taylor DJ (2023) Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system. Nat Commun 14(1):784. https:\/\/doi.org\/10.1038\/s41467-023-36463-7","journal-title":"Nat Commun"},{"issue":"9","key":"10825_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0968-0004(01)01935-1","volume":"26","author":"MS Weiss","year":"2001","unstructured":"Weiss MS, Brandl M, Suhnel J, Pal D, Hilgenfeld R (2001) More hydrogen bonds for the (structural) biologist. Trends Biochem Sci 26(9):521\u2013523. https:\/\/doi.org\/10.1016\/s0968-0004(01)01935-1","journal-title":"Trends Biochem Sci"},{"key":"10825_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2017.04.003","volume":"66","author":"MJ Seo","year":"2017","unstructured":"Seo MJ, Oh DK (2017) Prostaglandin synthases: molecular characterization and involvement in prostaglandin biosynthesis. Prog Lipid Res 66:50\u201368. https:\/\/doi.org\/10.1016\/j.plipres.2017.04.003","journal-title":"Prog Lipid Res"},{"issue":"22","key":"10825_CR46","doi-asserted-by":"publisher","first-page":"15327","DOI":"10.1021\/acs.jmedchem.2c01299","volume":"65","author":"B Hu","year":"2022","unstructured":"Hu B, Toda K, Wang X, Antczak MI, Smith J, Geboers S, Nishikawa G, Li H, Dawson D, Fink S, Desai AB, Williams NS, Markowitz SD, Ready JM (2022) Orally bioavailable quinoxaline inhibitors of 15-Prostaglandin dehydrogenase (15-PGDH) promote tissue repair and regeneration. J Med Chem 65(22):15327\u201315343. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01299","journal-title":"J Med Chem"},{"issue":"1","key":"10825_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43556-020-00025-w","volume":"2","author":"T Lan","year":"2021","unstructured":"Lan T, Wei X (2021) Inhibition of 15-PDGH: a strategy to rejuvenate aged muscles? Mol Biomed 2(1):14. https:\/\/doi.org\/10.1186\/s43556-020-00025-w","journal-title":"Mol Biomed"},{"key":"10825_CR48","doi-asserted-by":"publisher","unstructured":"Ahmad SS, Ahmad K, Lee EJ, Shaikh S, Choi I (2021) Computational identification of Dithymoquinone as a potential inhibitor of Myostatin and Regulator of muscle Mass. Molecules 26(17). https:\/\/doi.org\/10.3390\/molecules26175407","DOI":"10.3390\/molecules26175407"},{"key":"10825_CR49","doi-asserted-by":"publisher","unstructured":"Pang H, Lei D, Chen T, Liu Y, Fan C (2023) The enzyme 15-Hydroxyprostaglandin dehydrogenase inhibits a shift to the mesenchymal pattern of trophoblasts and decidual stromal cells accompanied by Prostaglandin Transporter in Preeclampsia. Int J Mol Sci 24(6). https:\/\/doi.org\/10.3390\/ijms24065111","DOI":"10.3390\/ijms24065111"},{"issue":"14","key":"10825_CR50","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1016\/j.bmc.2005.04.053","volume":"13","author":"A Hamza","year":"2005","unstructured":"Hamza A, Cho H, Tai HH, Zhan CG (2005) Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD\u2009+\u2009and PGE2 by homology modeling, docking and molecular dynamics simulation. Bioorg Med Chem 13(14):4544\u20134551. https:\/\/doi.org\/10.1016\/j.bmc.2005.04.053","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10825_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.abb.2004.09.036","volume":"433","author":"H Cho","year":"2005","unstructured":"Cho H, Hamza A, Zhan CG, Tai HH (2005) Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase. Arch Biochem Biophys 433(2):447\u2013453. https:\/\/doi.org\/10.1016\/j.abb.2004.09.036","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10825_CR52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1006\/bbrc.1999.0356","volume":"257","author":"H Zhou","year":"1999","unstructured":"Zhou H, Tai HH (1999) Threonine 188 is critical for interaction with NAD\u2009+\u2009in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem Biophys Res Commun 257(2):414\u2013417. https:\/\/doi.org\/10.1006\/bbrc.1999.0356","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10825_CR53","doi-asserted-by":"publisher","first-page":"e12029","DOI":"10.1371\/journal.pone.0012029","volume":"5","author":"R Patil","year":"2010","unstructured":"Patil R, Das S, Stanley A, Yadav L, Sudhakar A, Varma AK (2010) Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS ONE 5(8):e12029. https:\/\/doi.org\/10.1371\/journal.pone.0012029","journal-title":"PLoS ONE"},{"issue":"6","key":"10825_CR54","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1080\/07391102.2019.1615002","volume":"38","author":"J Vora","year":"2020","unstructured":"Vora J, Patel S, Athar M, Sinha S, Chhabria MT, Jha PC, Shrivastava N (2020) Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds. J Biomol Struct Dyn 38(6):1726\u20131740. https:\/\/doi.org\/10.1080\/07391102.2019.1615002","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"10825_CR55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1006\/jmbi.1994.1017","volume":"235","author":"VN Maiorov","year":"1994","unstructured":"Maiorov VN, Crippen GM (1994) Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins. J Mol Biol 235(2):625\u2013634. https:\/\/doi.org\/10.1006\/jmbi.1994.1017","journal-title":"J Mol Biol"},{"key":"10825_CR56","doi-asserted-by":"publisher","unstructured":"Sun CC, Zhou ZQ, Yang D, Chen ZL, Zhou YY, Wen W, Feng C, Zheng L, Peng XY, Tang CF (2021) Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol 101 (Pt B) 108176. https:\/\/doi.org\/10.1016\/j.intimp.2021.108176","DOI":"10.1016\/j.intimp.2021.108176"},{"issue":"11","key":"10825_CR57","doi-asserted-by":"publisher","first-page":"e13719","DOI":"10.1371\/journal.pone.0013719","volume":"5","author":"FH Niesen","year":"2010","unstructured":"Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A (2010) High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships. PLoS ONE 5(11):e13719. https:\/\/doi.org\/10.1371\/journal.pone.0013719","journal-title":"PLoS ONE"},{"issue":"6240","key":"10825_CR58","doi-asserted-by":"publisher","first-page":"aaa2340","DOI":"10.1126\/science.aaa2340","volume":"348","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen WD, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai HH, Gerson SL, Ready JM, Posner B, Willson JK, Markowitz SD (2015) Tissue regeneration. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348(6240):aaa2340. https:\/\/doi.org\/10.1126\/science.aaa2340","journal-title":"Science"},{"issue":"18","key":"10825_CR59","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.7150\/thno.63396","volume":"11","author":"H Cheng","year":"2021","unstructured":"Cheng H, Huang H, Guo Z, Chang Y, Li Z (2021) Role of prostaglandin E2 in tissue repair and regeneration. Theranostics 11(18):8836\u20138854. https:\/\/doi.org\/10.7150\/thno.63396","journal-title":"Theranostics"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10825-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10825-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:08:29Z","timestamp":1734610109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10825-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10825"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10825-9","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All co-authors have read and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This is a purely computational study and ethics approvals are not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}